Roles of macrophage migration inhibitory factor in Guillain-Barré syndrome and experimental autoimmune neuritis: beneficial or harmful?

References

• Song BH, Yun SI, Woolley M, et al. Zika virus: history, epidemiology, transmission, and clinical presentation. J Neuroimmunol. 2017 Jul 15;308:50–64. PubMed PMID: 28285789; eng.
   PubMed Web of Science ®Google Scholar
• Wang L, Shao C, Yang C, et al. Association of anti-gangliosides antibodies and anti-CMV antibodies in Guillain-Barre syndrome. Brain and Behavior. 2017 May;7(5):e00690. PubMed PMID: 28523231.
   PubMed Web of Science ®Google Scholar
• Zhang HL, Hassan MY, Zheng XY, et al. Attenuated EAN in TNF-alpha deficient mice is associated with an altered balance of M1/M2 macrophages. PloS One. 2012;7(5):e38157. PubMed PMID: 22666471; PubMed Central PMCID: PMCPmc3364226. eng.
   PubMed Web of Science ®Google Scholar
• Wang SS, Cen X, Liang XH, et al. Macrophage migration inhibitory factor: a potential driver and biomarker for head and neck squamous cell carcinoma. Oncotarget. 2017 Feb 07;8(6):10650–10661. PubMed PMID: 27788497; eng.
   PubMedGoogle Scholar
• Nicoletti F, Creange A, Orlikowski D, et al. Macrophage migration inhibitory factor (MIF) seems crucially involved in Guillain-Barre syndrome and experimental allergic neuritis. J Neuroimmunol. 2005 Nov;168(1–2):168–174. PubMed PMID: 16171874; eng.
   PubMed Web of Science ®Google Scholar
• Yukitake H, Takizawa M, Kimura H. Macrophage migration inhibitory factor as an emerging drug target to regulate antioxidant response element system. Oxid Med Cell. 2017;2017:8584930. PubMed PMID: 28191280.
   PubMedGoogle Scholar
• Kindt N, Journe F, Laurent G, et al. Involvement of macrophage migration inhibitory factor in cancer and novel therapeutic targets. Oncol Lett. 2016 Oct;12(4):2247–2253. PubMed PMID: 27698786; PubMed Central PMCID: PMCPmc5038338. eng.
   PubMed Web of Science ®Google Scholar
• Babu SN, Chetal G, Kumar S. Macrophage migration inhibitory factor: a potential marker for cancer diagnosis and therapy. Asian Pacific J Cancer Prev: APJCP. 2012;13(5): 1737–1744. PubMed PMID: 22901113; eng.
   PubMedGoogle Scholar
• Powell ND, Papenfuss TL, McClain MA, et al. Cutting edge: macrophage migration inhibitory factor is necessary for progression of experimental autoimmune encephalomyelitis. J Immunol (Baltimore, Md: 1950). 2005 Nov 01;175(9):5611–5614. PubMed PMID: 16237048; eng.
   PubMed Web of Science ®Google Scholar
• Meza-Romero R, Benedek G, Yu X, et al. HLA-DRalpha1 constructs block CD74 expression and MIF effects in experimental autoimmune encephalomyelitis. J Immunol (Baltimore, Md: 1950). 2014 May 01;192(9):4164–4173. PubMed PMID: 24683185; PubMed Central PMCID: PMCPmc4028955. eng.
   PubMed Web of Science ®Google Scholar
• Santos LL, Dacumos A, Yamana J, et al. Reduced arthritis in MIF deficient mice is associated with reduced T cell activation: down-regulation of ERK MAP kinase phosphorylation. Clin Exp Immunol. 2008 May;152(2):372–380. PubMed PMID: 18341611; PubMed Central PMCID: PMCPmc2384113. eng.
   PubMed Web of Science ®Google Scholar
• Santos LL, Morand EF. Macrophage migration inhibitory factor: a key cytokine in RA, SLE and atherosclerosis. Clin Chim Acta. 2009 Jan;399(1–2):1–7. PubMed PMID: 18838066; eng.
   PubMed Web of Science ®Google Scholar
• Sanchez-Zamora YI, Rodriguez-Sosa M. The role of MIF in type 1 and type 2 diabetes mellitus. J Diab res. 2014;2014:804519. PubMed PMID: 24527464.
   PubMedGoogle Scholar
• Zernecke A, Bernhagen J, Weber C. Macrophage migration inhibitory factor in cardiovascular disease. Circulation. 2008 Mar 25;117(12):1594–1602. PubMed PMID: 18362243; eng.
   PubMed Web of Science ®Google Scholar
• Hoi AY, Hickey MJ, Hall P, et al. Macrophage migration inhibitory factor deficiency attenuates macrophage recruitment, glomerulonephritis, and lethality in MRL/lpr mice. J Immunol (Baltimore, Md: 1950). 2006 Oct 15;177(8):5687–5696. PubMed PMID: 17015758; eng.
   PubMed Web of Science ®Google Scholar
• Nakajima H, Takagi H, Horiguchi N, et al. Lack of macrophage migration inhibitory factor protects mice against concanavalin A-induced liver injury. Liver Int: Off J Int Assoc Study Liver. 2006 Apr;26(3):346–351. PubMed PMID: 16584398; eng.
   PubMed Web of Science ®Google Scholar
• Shimizu T, Nishihira J, Mizue Y, et al. High macrophage migration inhibitory factor (MIF) serum levels associated with extended psoriasis. J Invest Dermatol. 2001 Jun;116(6):989–990. PubMed PMID: 11407993; eng.
   PubMed Web of Science ®Google Scholar
• Pohl J, Papathanasiou M, Heisler M, et al. Renal replacement therapy neutralizes elevated MIF levels in septic shock. J of Intensive Care. 2016;4:39. PubMed PMID: 27313864; PubMed Central PMCID: PMCPmc4910205. Eng.
   PubMed Web of Science ®Google Scholar
• Lai KN, Leung JC, Metz CN, et al. Role for macrophage migration inhibitory factor in acute respiratory distress syndrome. J Pathol. 2003 Apr;199(4):496–508. PubMed PMID: 12635141; eng.
   PubMed Web of Science ®Google Scholar
• O’Reilly C, Doroudian M, Mawhinney L, et al. Targeting MIF in cancer: therapeutic strategies, current developments, and future opportunities. Med Res Rev. 2016 May;36(3):440–460. PubMed PMID: 26777977; eng.
   PubMed Web of Science ®Google Scholar
• Lue H, Kleemann R, Calandra T, et al. Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease. Microbes and Infect. 2002 Apr;4(4):449–460. PubMed PMID: 11932196; eng.
   PubMed Web of Science ®Google Scholar
• Senter PD, Al-Abed Y, Metz CN, et al. Inhibition of macrophage migration inhibitory factor (MIF) tautomerase and biological activities by acetaminophen metabolites. Proc Natl Acad Sci U S A. 2002 Jan 08;99(1):144–149. PubMed PMID: 11773615; PubMed Central PMCID: PMCPmc117529. eng.
   PubMed Web of Science ®Google Scholar
• Bernhagen J, Krohn R, Lue H, et al. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat Med. 2007 May;13(5):587–596. PubMed PMID: 17435771; eng.
   PubMed Web of Science ®Google Scholar
• Kindt N, Laurent G, Nonclercq D, et al. Pharmacological inhibition of macrophage migration inhibitory factor interferes with the proliferation and invasiveness of squamous carcinoma cells. Int J Oncol. 2013 Jul;43(1):185–193. PubMed PMID: 23677331; eng.
   PubMed Web of Science ®Google Scholar
• Kindt N, Lechien JR, Nonclercq D, et al. Involvement of CD74 in head and neck squamous cell carcinomas. J Cancer Res Clin Oncol. 2014 Jun;140(6):937–947. PubMed PMID: 24663824; eng.
   PubMed Web of Science ®Google Scholar
• Soares TA, Lins RD, Straatsma TP, et al. Internal dynamics and ionization states of the macrophage migration inhibitory factor: comparison between wild-type and mutant forms. Biopolymers. 2002 Nov 15;65(4):313–323. PubMed PMID: 12382291; eng.
   PubMed Web of Science ®Google Scholar
• Healy ZR, Liu H, Holtzclaw WD, et al. Inactivation of tautomerase activity of macrophage migration inhibitory factor by sulforaphane: a potential biomarker for anti-inflammatory intervention. Cancer Epidemiol, Biomarkers Prev: Publ Am Assoc Cancer Res, Cosponsored by Am Soc Prev Oncol. 2011 Jul;20(7):1516–1523. 10.1158/1055-9965.epi-11-0279. PubMed PMID: 21602309; PubMed Central PMCID: PMCPmc3132381. eng.
   Google Scholar
• Nishihira J, Koyama Y, Mizue Y. Identification of macrophage migration inhibitory factor (MIF) in human vascular endothelial cells and its induction by lipopolysaccharide. Cytokine. 1998 Mar;10(3):199–205. PubMed PMID: 9576065; eng.
   PubMed Web of Science ®Google Scholar
• Petrovsky N, Socha L, Silva D, et al. Macrophage migration inhibitory factor exhibits a pronounced circadian rhythm relevant to its role as a glucocorticoid counter-regulator. Immunol Cell Biol. 2003 Apr;81(2):137–143. PubMed PMID: 12631237; eng.
   PubMed Web of Science ®Google Scholar
• Calandra T, Bernhagen J, Metz CN, et al. MIF as a glucocorticoid-induced modulator of cytokine production. Nature. 1995 Sep 07;377(6544):68–71. PubMed PMID: 7659164; eng.
   PubMed Web of Science ®Google Scholar
• Roger T, Chanson AL, Knaup-Reymond M, et al. Macrophage migration inhibitory factor promotes innate immune responses by suppressing glucocorticoid-induced expression of mitogen-activated protein kinase phosphatase-1. Eur J Immunol. 2005 Dec;35(12):3405–3413. PubMed PMID: 16224818; eng.
   PubMed Web of Science ®Google Scholar
• Chuang TY, Chang HT, Chung KP, et al. High levels of serum macrophage migration inhibitory factor and interleukin 10 are associated with a rapidly fatal outcome in patients with severe sepsis. Inter J Infect Dis: IJID: Off Publ Inter Soc Infect Dis. 2014 Mar;20:13–17. PubMed PMID: 24445225; eng.
   PubMed Web of Science ®Google Scholar
• Falvey JD, Bentley RW, Merriman TR, et al. Macrophage migration inhibitory factor gene polymorphisms in inflammatory bowel disease: an association study in New Zealand Caucasians and meta-analysis. World J Gastroenterol. 2013 Oct 21;19(39):6656–6664. PubMed PMID: 24151396; PubMed Central PMCID: PMCPmc3801383. eng.
   PubMed Web of Science ®Google Scholar
• Amin MA, Haas CS, Zhu K, et al. Migration inhibitory factor up-regulates vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 via Src, PI3 kinase, and NFkappaB. Blood. 2006 Mar 15;107(6):2252–2261. 10.1182/blood-2005-05-2011. PubMed PMID: 16317091; PubMed Central PMCID: PMCPmc1472703. eng.
   PubMed Web of Science ®Google Scholar
• Kim KW, Kim HR. Macrophage migration inhibitory factor: a potential therapeutic target for rheumatoid arthritis. Korean J Intern Med. 2016 Jul;31(4):634–642. PubMed PMID: 27169879; PubMed Central PMCID: PMCPmc4939511. eng.
   PubMed Web of Science ®Google Scholar
• Carli C, Metz CN, Al-Abed Y, et al. Up-regulation of cyclooxygenase-2 expression and prostaglandin E2 production in human endometriotic cells by macrophage migration inhibitory factor: involvement of novel kinase signaling pathways. Endocrinology. 2009 Jul;150(7):3128–3137. PubMed PMID: 19299454; PubMed Central PMCID: PMCPmc2703510. eng.
   PubMed Web of Science ®Google Scholar
• Liu H, Chen G, Zhang W, et al. Overexpression of macrophage migration inhibitory factor in adenoid cystic carcinoma: correlation with enhanced metastatic potential. J Cancer Res Clin Oncol. 2013 Feb;139(2):287–295. PubMed PMID: 23064787; eng.
   PubMed Web of Science ®Google Scholar
• Roger T, David J, Glauser MP, et al. MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature. 2001 Dec 20– 27;414(6866):920–924. PubMed PMID: 11780066; eng.
   PubMed Web of Science ®Google Scholar
• Leech M, Lacey D, Xue JR, et al. Regulation of p53 by macrophage migration inhibitory factor in inflammatory arthritis. Arthritis Rheum. 2003 Jul;48(7):1881–1889. PubMed PMID: 12847682; eng.
   PubMedGoogle Scholar
• Bacher M, Metz CN, Calandra T, et al. An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci U S A. 1996 Jul 23;93(15):7849–7854. PubMed PMID: 8755565; PubMed Central PMCID: PMCPmc38837. eng.
   PubMed Web of Science ®Google Scholar
• Tillmann S, Bernhagen J, Noels H. Arrest Functions of the MIF Ligand/Receptor Axes in Atherogenesis. Front Immunol. 2013;4:115. PubMed PMID: 23720662; PubMed Central PMCID: PMCPmc3655399. eng.
   PubMed Web of Science ®Google Scholar
• Fan H, Hall P, Santos LL, et al. Macrophage migration inhibitory factor and CD74 regulate macrophage chemotactic responses via MAPK and Rho GTPase. J Immunol (Baltimore, Md: 1950). 2011 Apr 15;186(8):4915–4924. PubMed PMID: 21411731; PubMed Central PMCID: PMCPmc3388798. eng.
   PubMed Web of Science ®Google Scholar
• Gregory JL, Hall P, Leech M, et al. Independent roles of macrophage migration inhibitory factor and endogenous, but not exogenous glucocorticoids in regulating leukocyte trafficking. Microcirculation (New York, NY: 1994). 2009 Nov;16(8):735–748. 10.3109/10739680903210421. PubMed PMID: 19905972; PubMed Central PMCID: PMCPmc3070174. eng.
   PubMed Web of Science ®Google Scholar
• Zhu G, Tang Y, Geng N, et al. HIF-alpha/MIF and NF-kappaB/IL-6 axes contribute to the recruitment of CD11b+Gr-1+ myeloid cells in hypoxic microenvironment of HNSCC. Neoplasia (New York, NY). 2014 Feb;16(2):168–179. PubMed PMID: 24709424; PubMed Central PMCID: PMCPmc3978397. eng.
   PubMed Web of Science ®Google Scholar
• Okamoto T, Atsumi T, Shimizu C, et al. The potential role of macrophage migration inhibitory factor on the migration of vascular smooth muscle cells. J Atheroscler Thromb. 2008 Feb;15(1):13–19. PubMed PMID: 18270460; eng.
   PubMed Web of Science ®Google Scholar
• Dewor M, Steffens G, Krohn R, et al. Macrophage migration inhibitory factor (MIF) promotes fibroblast migration in scratch-wounded monolayers in vitro. FEBS Lett. 2007 Oct 02;581(24):4734–4742. PubMed PMID: 17854804; eng.
   PubMed Web of Science ®Google Scholar
• Schroder B. The multifaceted roles of the invariant chain CD74–more than just a chaperone. Biochim Biophys Acta. 2016 Jun;1863(6 Pt A):1269–1281. PubMed PMID: 27033518; eng.
   PubMed Web of Science ®Google Scholar
• Borghese F, Clanchy FI. CD74: an emerging opportunity as a therapeutic target in cancer and autoimmune disease. Expert Opin Ther Targets. 2011 Mar;15(3):237–251. PubMed PMID: 21208136; eng.
   PubMed Web of Science ®Google Scholar
• Liao H, Bucala R, Mitchell RA. Adhesion-dependent signaling by macrophage migration inhibitory factor (MIF). J Biol Chem. 2003 Jan 03;278(1):76–81. PubMed PMID: 12297513; eng.
   PubMed Web of Science ®Google Scholar
• Leng L, Metz CN, Fang Y, et al. MIF signal transduction initiated by binding to CD74. J Exp Med. 2003 Jun 02;197(11):1467–1476. PubMed PMID: 12782713; PubMed Central PMCID: PMCPmc2193907. eng.
   PubMed Web of Science ®Google Scholar
• Lo MC, Yip TC, Ngan KC, et al. Role of MIF/CXCL8/CXCR2 signaling in the growth of nasopharyngeal carcinoma tumor spheres. Cancer Lett. 2013 Jul 10;335(1):81–92. PubMed PMID: 23403077; eng.
   PubMed Web of Science ®Google Scholar
• Youn H, Son B, Kim W, et al. Dissociation of MIF-rpS3 complex and sequential NF-kappaB activation is involved in IR-induced metastatic conversion of NSCLC. J Cell Biochem. 2015 Nov;116(11):2504–2516. PubMed PMID: 25900216; eng.
   PubMed Web of Science ®Google Scholar
• Shi X, Leng L, Wang T, et al. CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex. Immunity. 2006 Oct;25(4):595–606. PubMed PMID: 17045821; PubMed Central PMCID: PMCPmc3707630. eng.
   PubMed Web of Science ®Google Scholar
• Lue H, Kapurniotu A, Fingerle-Rowson G, et al. Rapid and transient activation of the ERK MAPK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on JAB1/CSN5 and Src kinase activity. Cell Signal. 2006 May;18(5):688–703. PubMed PMID: 16122907; eng.
   PubMed Web of Science ®Google Scholar
• Veillat V, Carli C, Metz CN, et al. Macrophage migration inhibitory factor elicits an angiogenic phenotype in human ectopic endometrial cells and triggers the production of major angiogenic factors via CD44, CD74, and MAPK signaling pathways. J Clin Endocrinol Metab. 2010 Dec;95(12):E403–E12. PubMed PMID: 20829186; eng.
   PubMed Web of Science ®Google Scholar
• Watanabe H, Shimizu T, Nishihira J, et al. Ultraviolet A-induced production of matrix metalloproteinase-1 is mediated by macrophage migration inhibitory factor (MIF) in human dermal fibroblasts. J Biol Chem. 2004 Jan 16;279(3):1676–1683. PubMed PMID: 14581488; eng.
   PubMed Web of Science ®Google Scholar
• Jung H, Seong HA, Ha H. Critical role of cysteine residue 81 of macrophage migration inhibitory factor (MIF) in MIF-induced inhibition of p53 activity. J Biol Chem. 2008 Jul 18;283(29):20383–20396. PubMed PMID: 18502749; eng.
   PubMed Web of Science ®Google Scholar
• Alampour-Rajabi S, El Bounkari O, Rot A, et al. MIF interacts with CXCR7 to promote receptor internalization, ERK1/2 and ZAP-70 signaling, and lymphocyte chemotaxis. FASEB J: Off Publ Fed Am Soc Exp Biol. 2015 Nov;29(11):4497–4511. PubMed PMID: 26139098; eng.
   PubMed Web of Science ®Google Scholar
• Zhang D, Zhang G, Hayden MS, et al. A toll-like receptor that prevents infection by uropathogenic bacteria. Science (New York, NY). 2004 Mar 05;303(5663):1522–1526. PubMed PMID: 15001781; eng.
   Google Scholar
• Wang YZ, Liang QH, Ramkalawan H, et al. Expression of Toll-like receptors 2, 4 and 9 in patients with Guillain-Barre syndrome. Neuroimmunomodulation. 2012;19(1):60–68. PubMed PMID: 22067623; eng.
   PubMed Web of Science ®Google Scholar
• Lv W, Chen N, Lin Y, et al. Macrophage migration inhibitory factor promotes breast cancer metastasis via activation of HMGB1/TLR4/NF kappa B axis. Cancer Lett. 2016 Jun 01;375(2):245–255. PubMed PMID: 26952810; eng.
   PubMed Web of Science ®Google Scholar
• Smolinska MJ, Page TH, Urbaniak AM, et al. Hck tyrosine kinase regulates TLR4-induced TNF and IL-6 production via AP-1. J Immunol (Baltimore, Md: 1950). 2011 Dec 01;187(11):6043–6051. PubMed PMID: 22021612; eng.
   PubMed Web of Science ®Google Scholar
• Sainaghi PP, Collimedaglia L, Alciato F, et al. The expression pattern of inflammatory mediators in cerebrospinal fluid differentiates Guillain-Barre syndrome from chronic inflammatory demyelinating polyneuropathy. Cytokine. 2010 Aug;51(2):138–143. PubMed PMID: 20538476; eng.
   PubMed Web of Science ®Google Scholar
• Wang YZ, Tian FF, Liu H, et al. Macrophage migration inhibitory factor is necessary for the lipo-oligosaccharide-induced response by modulation of Toll-like receptor 4 in monocytes from GBS patients. J Neuroimmunol. 2013 Apr 15;257(1–2):67–75. PubMed PMID: 23411097; eng.
   PubMed Web of Science ®Google Scholar
• Stavitsky AB, Xianli J. In vitro and in vivo regulation by macrophage migration inhibitory factor (MIF) of expression of MHC-II, costimulatory, adhesion, receptor, and cytokine molecules. Cell Immunol. 2002 May-Jun;217(1–2):95–104. PubMed PMID: 12426005; eng.
   PubMed Web of Science ®Google Scholar
• Kopp E, Medzhitov R. Recognition of microbial infection by Toll-like receptors. Curr Opin Immunol. 2003 Aug;15(4):396–401. PubMed PMID: 12900270; eng.
   PubMed Web of Science ®Google Scholar
• Kabelitz D. Expression and function of Toll-like receptors in T lymphocytes. Curr Opin Immunol. 2007 Feb;19(1):39–45. PubMed PMID: 17129718; eng.
   PubMed Web of Science ®Google Scholar
• Klasen C, Ohl K, Sternkopf M, et al. MIF promotes B cell chemotaxis through the receptors CXCR4 and CD74 and ZAP-70 signaling. J Immunol (Baltimore, Md: 1950). 2014 Jun 1;192(11):5273–5284. PubMed PMID: 24760155; eng.
   PubMed Web of Science ®Google Scholar
• Farrugia M, Baron B. The role of toll-like receptors in autoimmune diseases through failure of the self-recognition mechanism. Inter J Inflam. 2017;2017:8391230. PubMed PMID: 28553556
   PubMed Web of Science ®Google Scholar
• Shen A, Yang J, Gu Y, et al. Lipopolysaccharide-evoked activation of p38 and JNK leads to an increase in ICAM-1 expression in Schwann cells of sciatic nerves. FEBS J. 2008 Sep;275(17):4343–4353. PubMed PMID: 18657190; eng.
   PubMed Web of Science ®Google Scholar
• Kharwar NK, Prasad KN, Singh K, et al. Polymorphisms of IL-17 and ICAM-1 and their expression in Guillain-Barre syndrome. Int J Neurosci. 2017 Aug;127(8):680–687. PubMed PMID: 27595159; eng.
   PubMed Web of Science ®Google Scholar
• Denkinger CM, Denkinger M, Kort JJ, et al. In vivo blockade of macrophage migration inhibitory factor ameliorates acute experimental autoimmune encephalomyelitis by impairing the homing of encephalitogenic T cells to the central nervous system. J Immunol (Baltimore, Md: 1950). 2003 Feb 01;170(3):1274–1282. PubMed PMID: 12538686; eng.
   PubMed Web of Science ®Google Scholar
• Matsui Y, Okamoto H, Jia N, et al. Blockade of macrophage migration inhibitory factor ameliorates experimental autoimmune myocarditis. J Mol Cell Cardiol. 2004 Aug;37(2):557–566. PubMed PMID: 15276025; eng.
   PubMed Web of Science ®Google Scholar
• Orlikowski D, Chazaud B, Plonquet A, et al. Monocyte chemoattractant protein 1 and chemokine receptor CCR2 productions in Guillain-Barre syndrome and experimental autoimmune neuritis. J Neuroimmunol. 2003 Jan;134(1–2):118–127. PubMed PMID: 12507779; eng.
   PubMed Web of Science ®Google Scholar
• Chiang S, Ubogu EE. The role of chemokines in Guillain-Barre syndrome. Muscle Nerve. 2013 Sep;48(3):320–330. PubMed PMID: 23447114; PubMed Central PMCID: PMCPmc4024180. eng.
   PubMed Web of Science ®Google Scholar
• Zou LP, Pelidou SH, Abbas N, et al. Dynamics of production of MIP-1alpha, MCP-1 and MIP-2 and potential role of neutralization of these chemokines in the regulation of immune responses during experimental autoimmune neuritis in Lewis rats. J Neuroimmunol. 1999 Aug 03;98(2):168–175. PubMed PMID: 10430050; eng.
   PubMed Web of Science ®Google Scholar
• Xie J, Yang L, Tian L, et al. Macrophage migration inhibitor factor upregulates MCP-1 expression in an autocrine manner in hepatocytes during acute mouse liver injury. Sci Rep. 2016 Jun 8;6:27665. PubMed PMID: 27273604; PubMed Central PMCID: PMCPmc4897699. eng.
   PubMed Web of Science ®Google Scholar
• Lu MO, Zhu J. The role of cytokines in Guillain-Barre syndrome. J Neurol. 2011 Apr;258(4):533–548. PubMed PMID: 21104265; eng.
   PubMed Web of Science ®Google Scholar
• Greenhill CJ, Rose-John S, Lissilaa R, et al. IL-6 trans-signaling modulates TLR4-dependent inflammatory responses via STAT3. J Immunol (Baltimore, Md: 1950). 2011 Jan 15;186(2):1199–1208. PubMed PMID: 21148800; eng.
   PubMed Web of Science ®Google Scholar
• Onodera S, Nishihira J, Iwabuchi K, et al. Macrophage migration inhibitory factor up-regulates matrix metalloproteinase-9 and −13 in rat osteoblasts. Relevance to intracellular signaling pathways. J Biol Chem. 2002 Mar 08;277(10):7865–7874. PubMed PMID: 11751895; eng.
   PubMed Web of Science ®Google Scholar
• Cvetkovic I, Stosic-Grujicic S. Neutralization of macrophage migration inhibitory factor-novel approach for the treatment of immunoinflammatory disorders. Int Immunopharmacol. 2006 Oct;6(10):1527–1534. PubMed PMID: 16919824; eng.
   PubMed Web of Science ®Google Scholar
• Alexander JK, Cox GM, Tian JB, et al. Macrophage migration inhibitory factor (MIF) is essential for inflammatory and neuropathic pain and enhances pain in response to stress. Exp Neurol. 2012 Aug;236(2):351–362. PubMed PMID: 22575600; PubMed Central PMCID: PMCPmc3392533. eng.
   PubMed Web of Science ®Google Scholar
• Zhang HL, Zheng XY, Zhu J. Th1/Th2/Th17/Treg cytokines in Guillain-Barre syndrome and experimental autoimmune neuritis. Cytokine Growth Factor Rev. 2013 Oct;24(5):443–453. PubMed PMID: 23791985; eng.
   PubMed Web of Science ®Google Scholar
• Lerch JK, Puga DA, Bloom O, et al. Glucocorticoids and macrophage migration inhibitory factor (MIF) are neuroendocrine modulators of inflammation and neuropathic pain after spinal cord injury. Semin Immunol. 2014 Oct;26(5):409–414. PubMed PMID: 24768088; eng.
   PubMed Web of Science ®Google Scholar
• Nishio Y, Nishihira J, Ishibashi T, et al. Role of macrophage migration inhibitory factor (MIF) in peripheral nerve regeneration: anti-MIF antibody induces delay of nerve regeneration and the apoptosis of Schwann cells. Mol Med (Cambridge, Mass). 2002 Sep;8(9):509–520. PubMed PMID: 12456989; PubMed Central PMCID: PMCPmc2040017. eng.
   PubMed Web of Science ®Google Scholar
• Nishio Y, Minami A, Kato H, et al. Identification of macrophage migration inhibitory factor (MIF) in rat peripheral nerves: its possible involvement in nerve regeneration. Biochim Biophys Acta. 1999 Jan 06;1453(1):74–82. PubMed PMID: 9989247; eng.
   PubMed Web of Science ®Google Scholar
• Toh ML, Aeberli D, Lacey D, et al. Regulation of IL-1 and TNF receptor expression and function by endogenous macrophage migration inhibitory factor. J Immunol (Baltimore, Md: 1950). 2006 Oct 01;177(7):4818–4825. PubMed PMID: 16982923; eng.
   PubMed Web of Science ®Google Scholar
• Nyati KK, Prasad KN, Rizwan A, et al. TH1 and TH2 response to Campylobacter jejuni antigen in Guillain-Barre syndrome. Arch Neurol. 2011 Apr;68(4):445–452. PubMed PMID: 21482924; eng.
   PubMedGoogle Scholar
• Akcali A, Pehlivan S, Pehlivan M, et al. Association of macrophage migration inhibitory factor gene promoter polymorphisms with multiple sclerosis in Turkish patients. J Int Med Res. 2010 Jan-Feb;38(1):69–77. PubMed PMID: 20233515; eng.
   PubMed Web of Science ®Google Scholar
• Fukuyama S, Yoshino I, Yamaguchi M, et al. Blockage of the macrophage migration inhibitory factor expression by short interference RNA inhibited the rejection of an allogeneic tracheal graft. Transpl Inter: Off J Eur Soc Transplant. 2005 Oct;18(10):1203–1209. PubMed PMID: 16162108; eng.
   PubMed Web of Science ®Google Scholar
• Al-Abed Y, Metz CN, Cheng KF, et al. Thyroxine is a potential endogenous antagonist of macrophage migration inhibitory factor (MIF) activity. Proc Natl Acad Sci U S A. 2011 May 17;108(20):8224–8227. PubMed PMID: 21536912; PubMed Central PMCID: PMCPmc3100930. eng.
   PubMed Web of Science ®Google Scholar
• Dios A, Mitchell RA, Aljabari B, et al. Inhibition of MIF bioactivity by rational design of pharmacological inhibitors of MIF tautomerase activity. J Med Chem. 2002 Jun 06;45(12):2410–2416. PubMed PMID: 12036350; eng.
   PubMed Web of Science ®Google Scholar
• Cheng KF, Al-Abed Y. Critical modifications of the ISO-1 scaffold improve its potent inhibition of macrophage migration inhibitory factor (MIF) tautomerase activity. Bioorg Med Chem Lett. 2006 Jul 01;16(13):3376–3379. PubMed PMID: 16682188; eng.
   PubMed Web of Science ®Google Scholar
• Khoufache K, Bazin S, Girard K, et al. Macrophage migration inhibitory factor antagonist blocks the development of endometriosis in vivo. PloS One. 2012;7(5):e37264. PubMed PMID: 22649515; PubMed Central PMCID: PMCPmc3359359. eng.
   PubMed Web of Science ®Google Scholar
• Lubetsky JB, Dios A, Han J, et al. The tautomerase active site of macrophage migration inhibitory factor is a potential target for discovery of novel anti-inflammatory agents. J Biol Chem. 2002 Jul 12;277(28):24976–24982. PubMed PMID: 11997397; eng.
   PubMed Web of Science ®Google Scholar
• Crichlow GV, Cheng KF, Dabideen D, et al. Alternative chemical modifications reverse the binding orientation of a pharmacophore scaffold in the active site of macrophage migration inhibitory factor. J Biol Chem. 2007 Aug 10;282(32):23089–23095. PubMed PMID: 17526494; PubMed Central PMCID: PMCPmc3684284. eng.
   PubMed Web of Science ®Google Scholar
• Chen MF, Keng PC, Lin PY, et al. Caffeic acid phenethyl ester decreases acute pneumonitis after irradiation in vitro and in vivo. BMC Cancer. 2005 Dec 09;5:158. PubMed PMID: 16336675; PubMed Central PMCID: PMCPmc1325253. eng.
   PubMed Web of Science ®Google Scholar